Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrogen gas inhalation plus reduced-dose lithium for Alzheimer's dementia (H2LiTxDementia)
jRCT1091220303Recruiting
- Sponsor
- Hirohisa Ono
- Start
- Jul 2017
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised trial in Alzheimer's disease (AD) comparing Hydrogen gas inhalation plus lithium with Donepezil control (2 arms). Primary endpoints: Neurological improvement and Improvements in MRI indices. Started Jul 2017; status: recruiting.
02
Drugs
Molecular hydrogenlithiumdonepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on jRCT1091220303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220303.